首页 | 官方网站   微博 | 高级检索  
     

神经肌肉阻滞药及其拮抗药的临床应用及市场现状
引用本文:马美玲,刘文东,王芳. 神经肌肉阻滞药及其拮抗药的临床应用及市场现状[J]. 中国现代应用药学, 2017, 34(11): 1616-1620
作者姓名:马美玲  刘文东  王芳
作者单位:扬子江药业集团北京海燕药业有限公司, 北京 102206,扬子江药业集团北京海燕药业有限公司, 北京 102206,扬子江药业集团北京海燕药业有限公司, 北京 102206
摘    要:神经肌肉阻滞药是一种作用于外周神经系统、不具有中枢作用的肌肉松弛药,常作为手术麻醉时的辅助用药,但它的使用会导致阻滞残留作用,临床上常用拮抗药拮抗或者逆转其残留阻滞作用。本文总结了近年来神经肌肉阻滞药及其拮抗药的临床应用及市场现状,并阐述了其在国内的发展机遇和挑战。

关 键 词:神经肌肉阻滞药  拮抗药  临床用药  市场现状
收稿时间:2017-04-10
修稿时间:2017-05-27

Clinical Application and Market Status of Neuromuscular Blocking Agents and Antagonists
MA Meiling,LIU Wendong and WANG Fang. Clinical Application and Market Status of Neuromuscular Blocking Agents and Antagonists[J]. The Chinese Journal of Modern Applied Pharmacy, 2017, 34(11): 1616-1620
Authors:MA Meiling  LIU Wendong  WANG Fang
Affiliation:Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co. Ltd., Beijing 102206, China,Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co. Ltd., Beijing 102206, China and Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co. Ltd., Beijing 102206, China
Abstract:Neuromuscular blocking agents are a kind of muscle relaxants acting on the peripheral nervous system, which don''t have role of central nervous system. The drugs are widely used as anesthesia auxiliary drugs in surgery, but their use will often lead to residual neuromuscular block. In clinical practice, the antagonists are commonly used to antagonize or reverse the residual block effect. This paper summarizes the clinical application and market status of neuromuscular blocking agents and their antagonists in recent years, and describes the development opportunities and challenges in China.
Keywords:neuromuscular blocking agents  antagonists  clinical application  market status
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号